Gonadotropin-Releasing Hormone (GnRH) Analogs or Active Immunization Against GnRH To Control Fertility in Wildlife by Becker, Susan E. & Katz, Larry S.
University of Nebraska - Lincoln 
DigitalCommons@University of Nebraska - Lincoln 
Contraception in Wildlife Management USDA National Wildlife Research Center Symposia 
October 1993 
Gonadotropin-Releasing Hormone (GnRH) Analogs or Active 
Immunization Against GnRH To Control Fertility in Wildlife 
Susan E. Becker 
Larry S. Katz 
Follow this and additional works at: https://digitalcommons.unl.edu/nwrccontraception 
 Part of the Environmental Health and Protection Commons 
Becker, Susan E. and Katz, Larry S., "Gonadotropin-Releasing Hormone (GnRH) Analogs or Active 
Immunization Against GnRH To Control Fertility in Wildlife" (1993). Contraception in Wildlife Management. 
4. 
https://digitalcommons.unl.edu/nwrccontraception/4 
This Article is brought to you for free and open access by the USDA National Wildlife Research Center Symposia at 
DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Contraception in Wildlife 
Management by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln. 
Gonadotropin-Releasing Hormone (GnRH) Analogs 
or Active Immunization Against GnRH To Control 
Fertility in Wildlife 
Susan E. Becker and Larry S. Katz 
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Introduction 
Because hunting and natural mortality cannot control 
wildlife populations everywhere, there is increasing 
demand for the development of nonlethal methods for 
population control of both free-roaming and captive 
wildlife. Therefore, fertility control through administra- 
tion of contraceptive agents is being investigated. The 
ideal contraceptive agent should be (1) reversible (for 
some species), (2) suitable for remote delivery, 
(3) effective with only a single administration, (4) unable 
to contaminate the food chain, (5) without harmful side 
effects, and (6) without effect on social behavior. 
Although steroid hormone treatments have been used 
successfully for fertility control in nondomestic animals 
(see review by Kirkpatrick and Turner [1991]), the 
possibility exists for steroids to enter the food chain. A 
nonsteroidal hormone such as gonadotropin-releasing 
hormone (GnRH), a small peptide, would not pass 
through the food chain because when ingested it 
would be cleaved to its constituent amino acids. 
Relatively little work has been done to investigate the 
effectiveness of GnRH as a contraceptive agent in 
nondomestic species. 
Gonadotropin-releasing hormone, synthesized in 
the hypothalamus of both males and females, is a key 
regulator of reproduction in mammals. Released from 
the hypothalamus in a pulsatile pattern, it travels via 
the portal vasculature to the anterior pituitary, where it 
stimulates release of the gonadotropins, luteinizing 
hormone (LH), and follicle-stimulating hormone (FSH). 
These gonadotropins enter the circulation and regu- 
late both steroidogenesis and gamete maturation in 
the gonads (Conn 1994). More specifically, in the 
female, FSH stimulates follicular growth and matura- 
tion, and LH induces ovulation and corpus luteum 
formation. In the male, the direct role for FSH in 
spermatogenesis is uncertain, and LH causes the 
Leydig cells of the testis to produce testosterone 
which is necessary for gametogenesis. FSH, in the 
presence of LH, stimulates estradiol production from 
both the ovary and the testis. The steroids secreted 
from the gonads feed back to the hypothalamus and 
pituitary to regulate GnRH and gonadotropin synthesis 
and release (see fig. 1). 
It is possible to make the pituitary refractory to 
GnRH by administering GnRH, or an agonist of GnRH, 
in a continuous manner, rather than in the physiologi- 
cal pattern of pulses. Prolonged, continuous infusion 
of GnRH, especially at high concentrations, inhibits 
gonadotropin secretion (Belchetz et al. 1978), and that 
results in loss of gonadal function. Initially, pituitary 
desensitization is thought to result from loss of pituitary 
cell-surface receptors for GnRH by internalization of 
occupied receptors (Conn and Crowley 1991). Later, 
as receptor numbers recover due to recycling (Hazum 
and Conn 1988) and homologous upregulation (Conn 
et al. 1984, Braden and Conn 1990), desensitization 
may be maintained because the receptors become 
dissociated from their second messenger system 
(Conn and Crowley 1991). 
Controlling the amount and pattern of GnRH 
stimulation to the pituitary affects gonadotropin 
synthesis and secretion, thereby affording a potential 
method of controlling fertility in both males and 
females. Administration of GnRH agonists or antago- 
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Figure 1. Pathways of positive (+) and negative (-)feedback of 
gonadal steroids on the hypothalamic-pituitary axis in (A) the 
female and (B) the male. The effects of estradiol in the female are 
positive or negative, depending upon the stage of the estrous 
cycle. Question mark (?) indicates relatively insignificant effects 
nists, as well as immunization against GnRH, have 
been tested for their ability to suppress reproductive 
function in humans and domestic animals, yet little 
work has been done in this area with wildlife. 
GnRH and GnRH Agonists 
Large doses or chronic administration of GnRH or 
GnRH agonists can inhibit gonadotropin secretion by 
pituitary desensitization. Agonists are often preferred, 
both clinically and experimentally, over GnRH itself 
due to their increased potency. In general, they have 
a higher binding affinity for the GnRH receptors, are 
more resistant to enzymatic degradation, and/or have 
a longer half-life in the circulation. Following com- 
mencement of treatment with GnRH or its agonists, 
there is a transient period of increased gonadotropin 
secretion before the suppressive effects of pituitary 
desensitization are realized (Conn and Crowley 1991). 
This results in a delay of effect in both sexes. In 
females, this initial increase in gonadotropin secretion 
may induce estrus and ovulation, depending upon the 
reproductive status of the animal when treatment is 
begun. However, if a female were bred during this 
induced estrus, the continued administration of GnRH 
would likely terminate the pregnancy. 
In males, there seem to be species differences in 
the degree of desensitization possible in response to 
GnRH agonists (see review by Vickery [1986]). 
Depending upon the species, pituitary desensitization 
is not necessarily accompanied by a decline in test- 
osterone secretion and a suppression of spermatoge- 
nesis. However, when it is, testosterone supple- 
mentation may be necessary if maintenance of normal 
sexual behavior in males is desired (Vickery et al. 
1984). Given these shortcomings, GnRH agonists 
may not be useful as male contraceptives. Neverthe- 
less, they may have some application in control of 
androgen-stimulated aggressive behavior. 
GnRH Analogs or Active Immunization 
Against GnRHTo Control Fertility 
In Hawaiian monk seals (Atkinson et al. 1993) 
and free-ranging African elephants (Brown et al. 
1993), single injections of GnRH agonists have been 
tested for their ability to suppress testicular function, 
i.e. testosterone production, thereby controlling 
aggressive behavior. Male Hawaiian monk seals may 
exhibit a breeding behavior called "mobbing" when 
their numbers exceed those of the females by more 
than 2 3 .  The "mobbed" female or immature seal is 
severely injured and often dies (Atkinson et al. 1993). 
Atkinson and coworkers found that after a transient 
increase, serum testosterone concentrations were 
reduced to castrate levels for approximately 2 months 
in male monk seals following a single injection of a 
GnRH agonist. Effects on sexual and aggressive 
behavior could not be measured because no female 
seals were available. 
In the case of African elephants, males go into 
musth once or twice a year, during which time they are 
dangerously aggressive. Captive elephants in musth 
have injured and killed handlers (Brown et al. 1993). 
A single injection of a GnRH agonist caused an initial 
increase in serum LH and testosterone concentrations 
followed by a decline to baseline values. The one bull 
which was in musth at the time of treatment did not 
appear to be in musth after the decline in serum 
testosterone levels. Subsequent challenge with an 
intravenous injection of GnRH resulted in an attenu- 
ated LH response, suggesting partial desensitization 
of the pituitary. However, testosterone secretion was 
increased compared with controls, indicating a hyper- 
sensitivity to increases in GnRH-induced LH concen- 
trations (Brown et al. 1993). 
From these studies it appears that GnRH ago- 
nists show promise as agents that may decrease 
aggressive behavior by reducing serum concentra- 
tions of testosterone. This may be very useful in 
captive populations such as those in zoos. Yet it is 
important to note that some species, such as cattle, 
may respond to chronic treatment with GnRH agonists 
with an increase in testicular function, despite de- 
pressed pituitary function, as evidenced by elevated 
serum testosterone concentrations (Melson et al. 
1986). 
Another possible outcome of prolonged adminis- 
tration of GnRH agonists is the stimulation of both 
pituitary and testicular function, as described by 
Lincoln (1987). In that study, red deer stags received 
continuous infusion of a GnRH agonist for 72 days 
beginning after the rut in winter, a time when the 
testes are still secreting significant amounts of testos- 
terone. It was expected that testicular activity would 
be suppressed, causing the stags to cast their antlers 
prematurely. In fact, treatment with the agonist 
resulted in increases in plasma LH and testosterone 
concentrations, testes growth, and aggressive behav- 
ior, and did not affect time of antler casting. The wide 
variation in response of the hypothalamic-pituitary- 
gonadal axis to exogenous GnRH may be due to 
several factors, including (1) choice of agonist, (2) dose, 
(3) treatment regimen, (4) reproductive status of the 
animal, and (5) species. Clearly more research is 
needed to determine the usefulness of this approach. 
It has been well documented that continuous 
treatment with GnRH will suppress gonadotropin 
secretion in females (Nett et al. 1981, Adams et al. 
1986, Khalid et al. 1989). Inhibition of ovulation 
caused by chronic administration of GnRH agonists 
has been successful in several species, including 
dogs (Vickery et al. 1989), cattle (Herschler and 
Vickery 1981), sheep (McNeilly and Fraser 1987), 
horses (Montovan et al. 1990), stumptailed monkeys 
(Fraser et al. 1980, Fraser 1983), and macaques 
(Fraser et al. 1987). We recently attempted to inhibit 
secretion of LH in white-tailed deer does (Odocoileus 
virginianus) by continually infusing a GnRH analog 
(HistrelinTM), with the goal of preventing ovulation 
(Becker and Katz 1995). 
Briefly, four does received Histrelin at 8.3 kg1 
hour subcutaneously via osmotic minipump, for 
14 days during the breeding season. Controls were 
administered continuous saline infusions (n = 3). On 
Day 1 (Day 0 =day of minipump insertion), the 
Histrelin-infused group had a higher mean serum LH 
concentration than the control group (16.0 i 5.3 v. 0.9 
i 0.4 ngImL, respectively). By Day 2, mean LH 
concentrations did not differ between the groups and 
remained at baseline for the duration of infusion (fig. 
2). On Day 10, both groups received a subcutaneous 
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injection of 100 pg Histrelin to test the ability of the 
pituitary to respond to additional stimulation. At 4 hours 
after injection, the mean serum LH concentration for 
controls was 17.8 ?r 3.3 ng/mL and was still elevated 
at 10 hours. In contrast, serum LH concentrations in 
the Histrelin-infused group remained at baseline 
(0.5 ?r 0 ng/mL) (fig. 3). 
Apparently, continuous infusion of Histrelin 
caused pituitary desensitization. It was not possible to 
monitor the ovaries ultrasonically; however, serum 
progesterone concentrations did not indicate that any 
of the four does infused with Histrelin ovulated in 
response to the initial rise in serum LH concentrations. 
Further research is needed to determine if reproduc- 
tive status influences whether or not ovulation is 
induced (an undesirable side effect) during the transi- 
++ Control implant 
+ Histrelin implant 
1 U Day of treatment 
Figure 2. Effects of continuous administration of Histrelin (8.3 pg/ 
hour. subcutaneously; n = 4) or saline (confrol; n = 3) on daily 
mean serum LH concentrations. Box indicates day of Histrelin 
challenqe. 
tory increase in serum gonadotropin concentrations. 
The practicality of this approach is dependent upon 
development of a long-acting, slow-release prepara- 
tion of agonist that can also be remotely delivered. 
GnRH Antagonists 
Pituitary suppression may be achieved by administra- 
tion of antagonists of GnRH, which exert their effects 
by competing with endogenous GnRH, preventing 
sufficient GnRH occupation of receptors to stimulate 
gonadotropin secretion (Conn and Crowley 1991). 
The main advantage to using GnRH antagonists 
rather than agonists is that pituitary suppression is 
immediate. There is no initial increase in gonadotro- 
* 
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Figure 3. The LH response to a subcutaneous injection of 100 pg 
of Histrelin on Day 10 of the continuous Histrelin in = 4) or 
continuous saline in = 3) infuson period (Day 0 = day of implant 
insertion). 'denotes treatment difference ( P c  0.05). 
GnRH Analogs or Active Immunization 
Against GnRHTo Control Fertility 
pin secretion, which may stimulate the gonads. 
Unfortunately, these drugs are more expensive and 
require a higher dosage than the agonists, so they are 
best used for short-term treatment or instances where 
agonists are not effective (Vickery 1986). In males of 
several species, including rats, dogs, and monkeys, 
treatment with GnRH antagonists results in a decrease 
in serum LH and testosterone concentrations within 
hours, and that ultimately halts spermatogenesis 
(Vickery 1986). Choice of antagonist may be impor- 
tant, as evidenced by the work of Brown et al. (1993). 
They gave a single intramuscular injection of an 
antagonist to African elephant bulls that resulted in 
reduced basal and GnRH-stimulated serum LH and 
testosterone concentrations on Day 2 after injection. 
One of the bulls was in musth at the time of treatment 
but was no longer in musth by Day 2. In contrast, 
treatment of elephant bulls with a different antagonist 
of similar structure did not affect pituitary-testicular 
function, despite a higher dosage. 
Antagonists of GnRH have successfully inhibited 
LH secretion and prevented ovulation in several 
species, including cattle (Rieger et al. 1989), rats, 
dogs, monkeys, and humans (see review by Vickery 
119861). For example, weekly subcutaneous injections 
for 20 weeks beginning during the midluteal phase of 
the estrous cycle resulted in suppression of circulating 
LH concentrations (compared with controls), and 
inhibition of ovulation throughout the treatment period 
in marmoset monkeys (Hodges et al. 1992). This 
effect proved to be reversible. Despite these suc- 
cesses, fertility control for wildlife often requires long- 
term treatment, for which GnRH agonists are better 
suited. 
lmmunoneutralization of GnRH 
Another approach to inhibit gonadotropin secretion 
from the pituitary involves active immunization of an 
animal against endogenous GnRH. Because GnRH is 
a low-molecular weight, naturally occurring peptide, it 
is a weak immunogen. It must be adsorbed to a large, 
inert particle, such as charcoal, or covalently bound to 
a carrier protein, such as a serum albumin, to enhance 
immunogenicity. The latter seems to provide more 
consistent responses and higher antibody titers (see 
review by Jeffcoate and Keeling [1984]). Develop- 
ment of detectable antibody titers in the serum re- 
quires many weeks following primary immunization. 
Although booster immunizations are not essen- 
tial for the production of high antibody titers (Adams 
and Adams 1992), boosters almost always raise the 
existing antibody titers (see review by Schanbacher 
[1984]). Once titers are raised, circulating GnRH is 
recognized and bound by the anti-GnRH immuno- 
globulins before it reaches the pituitary, thereby 
suppressing LH secretion and usually FSH secretion 
(although not always to the same degree) and leading 
to an impairment of reproductive function. The degree 
of dysfunction appears to be correlated to the GnRH 
antibody titer; that is, the higher the titer, the greater 
the suppressive effects on reproduction (Lincoln et al. 
1982, Safir et al. 1987, Bailie et al. 1989). Unfortu- 
nately, immediate inhibition of reproductive function is 
not possible unless immunization against GnRH is 
passive (administration of GnRH antiserum rather than 
a GnRH conjugate functioning as an antigen). For 
example, injection of ewes with ovine GnRH antiserum 
approximately 10 hours prior to the LH surge pre- 
vented the surgc and blocked ovulation (Fraser and 
McNeilly 1982). Yet passive immunization ac ins! 
GnRH is not a practical method of fertility control 
because the effects are not long-lasting (Fraser et al. 
1984). Frequent injections of GnRH antisera are not 
only impractical but also pose a health threat to the 
animal (Schanbacher 1984). 
Active immunization against GnRH has success- 
fully suppressed gonadotropin secretion and gonadal 
function in a variety of species, including rats and 
rabbits (Ladd et al. 1988), pigs (Esbenshade and Britt 
1985, Awoniyi et al. 1987), sheep (Clarke et al. 1978, 
Adams and Adams 1986), horses (Garza et al. 1986, 
Safir et al. 1987), and cattle (Robertson et al. 1982, 
Adams and Adams 1990, Adams et al. 1993). How- 
ever, little work has been done to test the effective- 
ness of this approach for wildlife. Studies in which red 
deer stags were actively immunized against GnRH 
met with varying degrees of success (Lincoln et al. 
1982, Ataja et al. 1992, Freudenberger et al. 1993). 
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Effects on reproductive parameters ranged from a 
slight suppression of plasma LH concentrations 
compared with controls but no significant reduction of 
plasma testosterone concentrations (Ataja et al. 1992) 
to a significant decrease in testosterone levels com- 
pared with controls, testicular atrophy, and premature 
casting of antlers (Lincoln et al. 1982). Differences in 
the carrier protein used and the timing of the primary 
immunization with respect to reproductive season may 
account for this variability. When male and female 
wild Norway rats were actively immunized against 
GnRH, 100-percent sterility was attained for both 
sexes. In the males, testosterone was nondetectable, 
and testes were approximately 90-percent atrophied 
up to 11 months after vaccination (see Miller, this 
volume). Although these results are promising and 
immunoneutralizing GnRH is less costly than treat- 
ment with either GnRH agonists or antagonists, there 
can be large variation in response due to individual 
differences in the development of antibody titers. 
Conclusion 
None of the GnRH-related fertility control methods 
described herein meet all of the criteria of the ideal 
contraceptive agent outlined previously. One problem 
that may apply to any method of contraception in 
wildlife is the lack of consensus on the percentage of 
animals that must be rendered infertile to bring about 
the desired reduction in herd growth rate. Also, 
logistical and economic issues pertaining to delivery 
systems must be addressed. Perhaps the greatest 
problem with GnRH contraception is the resulting 
suppression of sexual behavior, which may affect 
social behavior and, consequently, social structure. 
This problem can be overcome by steroid supplemen- 
tation using implants, but then food-chain contamina- 
tion and the need to capture the animals to administer 
the treatment become issues that must be considered. 
However, inhibition of androgen-stimulated aggressive 
behavior may be desired in certain venues, such as 
zoos. In addition, care must be taken to ensure that 
the contraceptive activity of GnRH analog treatment 
lasts throughout the breeding season to avoid young 
being born when environmental conditions are unsuit- 
able for offspring survival. Treatment must abolish, 
not merely delay, the breeding season. Targeting 
GnRH function for contraception of wildlife meets four 
of the six criteria mentioned earlier for the ideal 
contraceptive agent. Treatment is reversible, suitable 
for remote delivery, and unable to contaminate the 
food chain. Additionally, single administration is 
possible for active immunization against GnRH (and 
will be possible for GnRH agonists following the 
development of long-lasting, injectable microcap- 
sules). Gonadotropin-releasing hormone contracep- 
tion should be further investigated for potential 
applications in wildlife management. 
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